APA (7th ed.) Citation

Adams, D. B., & Kristen, A. (2018). Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. The New England journal of medicine, 379(1), . https://doi.org/10.1056/NEJMoa1716153

Chicago Style (17th ed.) Citation

Adams, David B., and Arnt Kristen. "Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis." The New England Journal of Medicine 379, no. 1 (2018). https://doi.org/10.1056/NEJMoa1716153.

MLA (9th ed.) Citation

Adams, David B., and Arnt Kristen. "Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis." The New England Journal of Medicine, vol. 379, no. 1, 2018, https://doi.org/10.1056/NEJMoa1716153.